StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the stock.
China Pharma Stock Performance
NYSE CPHI opened at $0.25 on Friday. China Pharma has a 52 week low of $0.24 and a 52 week high of $2.05. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.25 and a current ratio of 0.89. The company has a 50-day moving average price of $0.30 and a two-hundred day moving average price of $0.40.
China Pharma (NYSE:CPHI – Get Free Report) last posted its earnings results on Wednesday, May 15th. The company reported ($0.07) EPS for the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%. The firm had revenue of $1.37 million during the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- Technology Stocks Explained: Here’s What to Know About Tech
- Micron Technology Stock Volatile Despite Analyst Upgrades
- What is a Dividend King?
- McDonald’s Stock: Balancing Value and Innovation
- Investing in Construction Stocks
- MarketBeat Week in Review – 6/17 – 6/21
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
